Literature DB >> 7963682

Junctional epidermolysis bullosis: defects in expression of epiligrin/nicein/kalinin and integrin beta 4 that inhibit hemidesmosome formation.

S G Gil1, T A Brown, M C Ryan, W G Carter.   

Abstract

Junctional epidermolysis bullosis (JEB) is a heterogeneous inherited blistering disorder of human epithelial basement membranes (BMs). Characteristically, the epidermis detaches from the BM between the basal cells and the lamina lucida due to reduced numbers of hemidesmosomes (HDs). Attempts to identify a candidate gene for JEB led to the characterization of nicein, a protein complex in normal BMs that is absent from BMs of patients with JEB gravis. In independent research, two related BM glycoproteins, epiligrin and kalinin, were identified as functional adhesion components of HDs. Epiligrin was characterized as a BM ligand for basal cell adhesion via integrins alpha 3 beta 1 in focal adhesions and alpha 6 beta 4 in HDs. Kalinin was characterized as an adhesive ligand and a component of anchoring filaments. Recent antibody and sequence studies on epiligrin/nicein/kalinin have identified limited homologies with laminin. Ongoing studies in multiple laboratories seek to identify mutations in one or more of the three subunits of epiligrin that are causal in JEB gravis. Consistent with the genetic heterogeneity of JEB, we have identified a patient with a variant form of JEB that is associated with pyloric atresia. This patient has negligible HDs, normal epiligrin, but reduced expression of integrin beta 4. A defect in the beta 4 expression may define a subset of JEB cases that also present with pyloric atresia. These results testify to the dual requirements for epiligrin in the BM and integrin beta 4 in the plasma membrane in regulating function of HDs in epithelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963682     DOI: 10.1111/1523-1747.ep12398953

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  Identification of a novel structural variant of the alpha 6 integrin.

Authors:  T L Davis; I Rabinovitz; B W Futscher; M Schnölzer; F Burger; Y Liu; M Kulesz-Martin; A E Cress
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

2.  IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa.

Authors:  J E Kuster; M H Guarnieri; J G Ault; L Flaherty; P J Swiatek
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

3.  Deletion of the laminin alpha4 chain leads to impaired microvessel maturation.

Authors:  Jill Thyboll; Jarkko Kortesmaa; Renhai Cao; Raija Soininen; Ling Wang; Antti Iivanainen; Lydia Sorokin; Mårten Risling; Yihai Cao; Karl Tryggvason
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  Epidermolysis bullosa with pyloric atresia: novel mutations in the beta4 integrin gene (ITGB4).

Authors:  L Pulkkinen; D U Kim; J Uitto
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

5.  A homozygous mutation in the integrin alpha6 gene in junctional epidermolysis bullosa with pyloric atresia.

Authors:  L Ruzzi; L Gagnoux-Palacios; M Pinola; S Belli; G Meneguzzi; M D'Alessio; G Zambruno
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

6.  Topical application of laminin-332 to diabetic mouse wounds.

Authors:  Stephen R Sullivan; Robert A Underwood; Randall O Sigle; Yuko Fukano; Lara A Muffley; Marcia L Usui; Nicole S Gibran; Marcos A Antezana; William G Carter; John E Olerud
Journal:  J Dermatol Sci       Date:  2007-08-24       Impact factor: 4.563

7.  Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense.

Authors:  L Pulkkinen; F Rouan; L Bruckner-Tuderman; R Wallerstein; M Garzon; T Brown; L Smith; W Carter; J Uitto
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

Review 8.  The molecular basis for inherited bullous diseases.

Authors:  B P Korge; T Krieg
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

9.  Down-regulation of laminin-5 in breast carcinoma cells.

Authors:  K J Martin; C P Kwan; K Nagasaki; X Zhang; M J O'Hare; C M Kaelin; R E Burgeson; A B Pardee; R Sager
Journal:  Mol Med       Date:  1998-09       Impact factor: 6.354

10.  Cellular interaction of integrin alpha3beta1 with laminin 5 promotes gap junctional communication.

Authors:  P D Lampe; B P Nguyen; S Gil; M Usui; J Olerud; Y Takada; W G Carter
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.